Cronos Group Inc. ( CRON) - Key Metrics
CRON Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.18 | $0.08 | $0.05 | $0.04 |
| 2026Q1 | $0.12 | $0.04 | $0.03 | $0.02 |
| 2025Q4 | $0.24 | $0 | $0.03 | $0.03 |
| 2025Q3 | $0.09 | $0.07 | $0.03 | $0.02 |
| 2025Q2 | $0.09 | -$0.10 | $0.01 | $0 |
CRON Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 8.34 |
| 2026Q1 | 0% | 17.58 |
| 2025Q4 | 0% | -139.89 |
| 2025Q3 | 0% | 10.37 |
| 2025Q2 | 0% | -4.77 |
CRON Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 1.59% | 0% |
| 2026Q1 | 0.92% | 0% |
| 2025Q4 | 0.97% | 0% |
| 2025Q3 | 0.81% | 0% |
| 2025Q2 | -0.14% | 0% |
CRON
Price: $3.22
52 week price:
Payout Ratio Range:
Earnings Per Share: 0.20 USD
P/E Ratio: 15.85
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: Canada
Volume: 1.5 million
Market Capitalization: 1.2 billion